Ingevity Corporation (NYSE:NGVT) Receives Average Recommendation of “Hold” from Brokerages

Shares of Ingevity Corporation (NYSE:NGVT) have earned an average recommendation of “Hold” from the five analysts that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating on the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $80.00.

Several brokerages have recently issued reports on NGVT. Wall Street Zen raised Ingevity from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, July 7th. Weiss Ratings restated a “sell (d-)” rating on shares of Ingevity in a research report on Friday, July 17th.

Insider Buying and Selling

In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of the firm’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $68.49, for a total transaction of $33,971.04. Following the completion of the transaction, the senior vice president owned 7,202 shares of the company’s stock, valued at approximately $493,264.98. This trade represents a 6.44% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.88% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. Principal Financial Group Inc. lifted its position in Ingevity by 269.9% during the 4th quarter. Principal Financial Group Inc. now owns 652,237 shares of the company’s stock valued at $38,599,000 after acquiring an additional 475,907 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Ingevity by 311.8% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock worth $23,769,000 after purchasing an additional 454,579 shares during the period. Simcoe Capital Management LLC grew its holdings in Ingevity by 188.8% in the second quarter. Simcoe Capital Management LLC now owns 624,935 shares of the company’s stock worth $26,928,000 after purchasing an additional 408,508 shares during the period. Boston Partners increased its stake in shares of Ingevity by 141.6% during the fourth quarter. Boston Partners now owns 620,360 shares of the company’s stock valued at $36,719,000 after purchasing an additional 363,584 shares in the last quarter. Finally, Bessemer Group Inc. increased its stake in shares of Ingevity by 465.9% during the first quarter. Bessemer Group Inc. now owns 314,739 shares of the company’s stock valued at $22,419,000 after purchasing an additional 259,124 shares in the last quarter. 91.59% of the stock is currently owned by institutional investors.

Ingevity Price Performance

Shares of NYSE NGVT opened at $73.28 on Friday. Ingevity has a 1 year low of $39.74 and a 1 year high of $79.29. The company has a debt-to-equity ratio of 27.83, a current ratio of 1.42 and a quick ratio of 0.92. The company’s 50-day moving average is $71.08 and its 200 day moving average is $70.62. The stock has a market capitalization of $2.55 billion, a P/E ratio of -20.64 and a beta of 1.16.

Ingevity (NYSE:NGVT) last released its quarterly earnings results on Wednesday, May 6th. The company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.84 by $0.31. Ingevity had a negative net margin of 10.55% and a positive return on equity of 207.82%. The company had revenue of $258.00 million during the quarter, compared to the consensus estimate of $254.73 million. During the same period in the prior year, the firm earned $1.01 earnings per share. Ingevity’s revenue was up 4.1% on a year-over-year basis. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. On average, sell-side analysts expect that Ingevity will post 5.05 earnings per share for the current year.

Ingevity Company Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.